Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06774443

Hinting Task for Huntington's Disease

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder, characterized by movement disorders, behavioural disorders and cognitive decline. Especially the behavioural and cognitive symptoms of the disease lead to significant disability and burden for patients as well as caregivers. One of the cognitive domains affected by HD is social cognition. Social cognition is the ability to perceive, interpret and respond correctly to social information. Aspects of social cognition are emotion recognition, perspective taking (Theory of Mind), and emapathy. Social cognition problems can be related to behavioural problems, but to be able to study this relationship, it is important to be able to reliable measure social cognition impairments. There are a few social cognition tests available, but often they are not normd and validated for use in a Dutch neurological population. There is a lack of sensitive, simple, tests for measuring Theory of Mind in patients with HD. A promising test, that already has been proven valid in a psychiatric population, is the Hinting Task. The Hinting Task measures theory of mind through indirect speech, The Hinting task is a social cognition test, where hints are implicitly given in speech, which resembles what patients and caregivers frequently report as difficult in HD. The Hinting Task has already been translated into Dutch and is already being used in clinical parctice, but its sensitivity has not been studied yet in a neurological population. The aim of this study is to assess if the Hinting Task is sensitive in patients with HD and to relate the Hinting Task to other (social) cognitive measures, demographical characteristics and disease characteristics.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–74 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Medical Center Groningen

Groningen, Provincie Groningen, 9700RB, Netherlands

Location status: Recruiting

Location contact

Floor Gelmers

CONTACT

[email protected]

+31 50 361 46 64

Maraike Coenen

CONTACT

[email protected]

Maraike Coenen

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed diagnosis of Huntington's disease via CAG-repeat length analysis, minimum of 40 repeats
  • Between 18 and 74 years of age
  • Dutch speaking

Exclusion criteria

  • Presence of serious psychiatric disorders or other neurological comorbidities

Treatment and study plan

Neuropsychological assessment

Other

Neuropsychological assessment consisting of tests measuring social cognition and memory

Primary outcomes

  1. Performance on the Hinting Task

    Time frame: 2025-2026

    Performance on the Hinting Task by patients with Huntington's disease compared to healthy controls

Secondary outcomes

  1. Relations of the Hinting Task with other variables

    Time frame: 2025-2026

    Relationship of the Hinting Task with other (social) cognitive tests, disease characteristics and demographical characteristics

Study contacts

Contact information is provided by the study sponsor or research team.

Floor Gelmers

CONTACT

[email protected]

+31 50 361 46 64

Maraike A. Coenen

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

University Medical Center Groningen

Other

Registry information

Official study title

Sensitivity of the Hinting Task in Patients With Huntington's Disease

Acronym: HT-HD

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jan 14, 2025
Registry last updated
Jan 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.